ATE229983T1 - Maspin- ein neues serpin mit tumor unterdrückender aktivität - Google Patents

Maspin- ein neues serpin mit tumor unterdrückender aktivität

Info

Publication number
ATE229983T1
ATE229983T1 AT93921337T AT93921337T ATE229983T1 AT E229983 T1 ATE229983 T1 AT E229983T1 AT 93921337 T AT93921337 T AT 93921337T AT 93921337 T AT93921337 T AT 93921337T AT E229983 T1 ATE229983 T1 AT E229983T1
Authority
AT
Austria
Prior art keywords
maspin
suppressing activity
tumor suppressing
serpin
new
Prior art date
Application number
AT93921337T
Other languages
English (en)
Inventor
Ruth Sager
Zhiqiang Zou
Anthony Anisowicz
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE229983T1 publication Critical patent/ATE229983T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT93921337T 1992-09-01 1993-09-01 Maspin- ein neues serpin mit tumor unterdrückender aktivität ATE229983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93882392A 1992-09-01 1992-09-01
PCT/US1993/008322 WO1994005804A1 (en) 1992-09-01 1993-09-01 Maspin, a novel serpin with tumor suppressing activity

Publications (1)

Publication Number Publication Date
ATE229983T1 true ATE229983T1 (de) 2003-01-15

Family

ID=25472030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921337T ATE229983T1 (de) 1992-09-01 1993-09-01 Maspin- ein neues serpin mit tumor unterdrückender aktivität

Country Status (6)

Country Link
EP (1) EP0662150B1 (de)
JP (1) JP3489629B2 (de)
AT (1) ATE229983T1 (de)
CA (1) CA2143188A1 (de)
DE (1) DE69332583T2 (de)
WO (1) WO1994005804A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
JP2002085093A (ja) * 2000-09-08 2002-03-26 Kuo Kwang Biotech Corp 扁平上皮細胞癌患者の生存予測
WO2007095583A2 (en) * 2006-02-14 2007-08-23 Children's Memorial Research Center Methods for treating cancer and sensitizing cancer cells using the serine protease inhibitor, maspin
EP3487965B1 (de) * 2016-07-20 2022-02-09 The Lubrizol Corporation Alkylphosphataminsalze zur verwendung in schmierstoffen
CN113677361A (zh) * 2018-12-28 2021-11-19 株式会社Neogentc 包含表达mal的干细胞样记忆t细胞作为活性成分的免疫增强或抗癌活性增强的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
EP0631584A4 (de) * 1991-02-28 1998-07-01 Dana Farber Cancer Inst Inc Krebs diagnose und therapie.

Also Published As

Publication number Publication date
DE69332583D1 (de) 2003-01-30
WO1994005804A1 (en) 1994-03-17
JP3489629B2 (ja) 2004-01-26
CA2143188A1 (en) 1994-03-17
EP0662150A4 (de) 1997-01-29
DE69332583T2 (de) 2003-11-20
EP0662150A1 (de) 1995-07-12
JPH08500977A (ja) 1996-02-06
EP0662150B1 (de) 2002-12-18

Similar Documents

Publication Publication Date Title
AU601144B2 (en) Cytotoxic protein
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
DK0751992T3 (da) Karendotelvækstfaktor 2
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
CA2108473A1 (en) Heregulins (hrgs) binding proteins of p185erb2
DE69428214D1 (de) Transformierender wachstumsfaktor alpha h1
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
ATE132197T1 (de) Monoklonale antikörper
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
SE9002589L (sv) Neutrofil-aktiverande peptid-2
Van Damme et al. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
Ando et al. Natural human interferon‐γ derived from lipopolysaccharide‐stimulated human myelomonocytic HBL‐38 cells
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ATE195342T1 (de) Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie
DK193187A (da) Interferoninduceret humanprotein paa ren form, dets fremstilling og anvendlese
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
JPS6410998A (en) Tumor cell inhibitory factor
Reid et al. Chemical, physical and electron microscopy studies of fragments produced by limited proteolysis of human C1q by pepsin
EP1019500A4 (de) Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
Yasuda et al. Partial purification and characterization of feline gamma-like interferon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties